Related references
Note: Only part of the references are listed.CD4+count and risk of non-AIDS diseases following initial treatment for HIV infection
Jason V. Baker et al.
AIDS (2008)
Risk of cancers during interrupted antiretroviral therapy in the SMART study
Michael J. Silverberg et al.
AIDS (2007)
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study
A. Mocroft et al.
LANCET (2007)
Evidence of ongoing immune reconstitution in subjects with sustained viral suppression following 6 years of lopinavir-ritonavir treatment
Alan Landay et al.
CLINICAL INFECTIOUS DISEASES (2007)
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression
Richard D. Moore et al.
CLINICAL INFECTIOUS DISEASES (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1:: results of the Staccato randomised trial
Jintanat Ananworanich et al.
LANCET (2006)
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: Results from ACTG 384
Rajesh T. Gandhi et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy:: Association of immune activation, T cell maturation markers, and cellular HIV-1 DNA
Miguel Goicoechea et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
A pilot study evaluating time to CD4 T-cell count < 350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: Results of ACTG A5102
Keith Henry et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy
DM Moore et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/μL in HIV type 1-infected individuals receiving potent antiretroviral therapy
GR Kaufmann et al.
CLINICAL INFECTIOUS DISEASES (2005)
Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
F García et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Immunophenotypic markers and antiretroviral therapy (IMART): T cell activation and maturation help predict treatment response
D Mildvan et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection
GK Robbins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection
RW Shafer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years - The Swiss HIV cohort study
GR Kaufmann et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection
CG Lange et al.
AIDS (2003)
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
PW Hunt et al.
AIDS (2003)
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease:: Association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes
RC Kalayjian et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?
E Wood et al.
AIDS (2003)
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies
M Egger et al.
LANCET (2002)
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count >350 X 106/l
M Opravil et al.
AIDS (2002)
HIV preferentially infects HIV-specific CD4+ T cells
DC Douek et al.
NATURE (2002)
The naive CD4+count in HIV-1-infected patients at time of initiation of highly active antiretroviral therapy is strongly associated with the level of immunological recovery
CG Michael et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2002)
Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy
RS Hogg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Immune restoration and CD4+T-cell function with antiretroviral therapies
MM Lederman
AIDS (2001)
Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase
MM Lederman et al.
AIDS (2000)
被撤回的出版物: HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death (Retracted article. See vol. 120, pg. 3401, 2010)
SJ Brodie et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Effect of HIV on thymic function before and after antiretroviral therapy in children
DC Douek et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
